News + Filings Transactions
|
Hawkins Richard J
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/01/2023 | LUMOS PHARMA, INC. | NLNK | Payment of Exercise | Common Stock | 1.5k | $3.31 | $5k | | 04/01/2023 |
| 03/03/2023 | PLUS THERAPEUTICS, INC. | CYTX | Purchase | Series F Preferred Stock | 1 | $1,000.00 | $1000 | | 03/03/2023 |
| 12/13/2022 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 40k | $1.51 | $60.4k | | 12/13/2022 |
| 12/07/2022 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 1.2k | $0.65 | $761.8 | | 12/07/2022 |
| 09/23/2022 | LUMOS PHARMA, INC. | NLNK | Purchase | Common Stock | 208 | $8.80 | $1.8k | By Charitable Trust | 09/21/2022 |
| 09/21/2022 | LUMOS PHARMA, INC. | NLNK | Purchase | Common Stock | 2.2k | $8.84 | $19.6k | By Charitable Trust | 09/21/2022 |
| 09/20/2022 | LUMOS PHARMA, INC. | NLNK | Purchase | Common Stock | 1.5k | $8.75 | $13.2k | By Charitable Trust | 09/19/2022 |
| 09/19/2022 | LUMOS PHARMA, INC. | NLNK | Purchase | Common Stock | 541 | $8.65 | $4.7k | By Charitable Trust | 09/19/2022 |
| 04/01/2022 | LUMOS PHARMA, INC. | NLNK | Payment of Exercise | Common Stock | 1.5k | $9.23 | $13.5k | | 04/01/2022 |
| 12/14/2021 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 40k | $1.11 | $44.4k | | 12/13/2021 |
| 12/13/2021 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 728 | $0.55 | $400.4 | | 12/13/2021 |
| 06/11/2021 | PLUS THERAPEUTICS, INC. | CYTX | Grant | Stock Option (Right to Buy) | 40k | $2.88 | $115.2k | | 06/11/2021 |
| 06/11/2021 | PLUS THERAPEUTICS, INC. | CYTX | Grant | Stock Option (Right to Buy) | 6.3k | $2.88 | $18.2k | | 06/11/2021 |
| 04/01/2021 | LUMOS PHARMA, INC. | NLNK | Payment of Exercise | Common Stock | 1.5k | $12.25 | $18.6k | | 04/01/2021 |
| 02/01/2021 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 2.3k | $0.00 | $0 | | 02/01/2021 |
| 02/01/2021 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 28.5k | $17.35 | $494k | | 02/01/2021 |
| 12/16/2020 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 40k | $1.23 | $49.2k | | 12/16/2020 |
| 04/01/2020 | LUMOS PHARMA, INC. | NLNK | Grant | Common Stock | 25k | $0.00 | $0 | | 04/01/2020 |
| 04/01/2020 | LUMOS PHARMA, INC. | NLNK | Grant | Stock Option (Right to Buy) | 135k | $7.87 | $1.1M | | 04/01/2020 |
| 12/20/2019 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 12k | $1.59 | $19.1k | | 12/20/2019 |
| 05/15/2019 | Savara Inc | SVRA | Sale | Common Stock | 10.4k | $11.16 | $116.2k | | 05/14/2019 |
| 05/14/2019 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 21.7k | $0.52 | $11.3k | | 05/14/2019 |
| 05/14/2019 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 586 | $0.52 | $304.7 | | 05/14/2019 |
| 05/14/2019 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 2.3k | $0.52 | $1.2k | | 05/14/2019 |
| 05/14/2019 | Savara Inc | SVRA | Exercise | Stock Option (Right to Buy) | 444 | $0.55 | $244.2 | | 05/14/2019 |
| 05/14/2019 | Savara Inc | SVRA | Sale | Common Stock | 14.6k | $11.07 | $161.5k | | 05/14/2019 |
| 12/13/2018 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 12k | $7.33 | $88k | | 12/13/2018 |
| 07/25/2018 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Subscription Rights (Right to Buy) | 10 | $1,000.00 | $10k | | 07/25/2018 |
| 07/25/2018 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Series C Preferred Stock | 10 | $0.80 | $8 | | 07/25/2018 |
| 07/25/2018 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Warrants (Right to Buy) | 10.5k | $0.80 | $8.4k | | 07/25/2018 |
| 12/17/2017 | Savara Inc | SVRA | Grant | Stock Option (Right to Buy) | 3.8k | $15.21 | $57k | | 12/17/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Subscription Rights (Right to Buy) | 3 | $1,000.00 | $3k | | 11/28/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Series B Preferred Stock | 3 | $0.33 | $1 | | 11/28/2017 |
| 11/28/2017 | PLUS THERAPEUTICS, INC. | CYTX | Exercise (in-the-money or at-the-money) | Warrants (Right to Buy) | 5.4k | $0.33 | $1.8k | | 11/28/2017 |
| 06/08/2017 | SCICLONE PHARMACEUTICALS INC | SCLN | Grant | | 30k | $10.90 | $327k | | 06/08/2017 |
|
|